5-Aminosalicylic acid therapy and the ri
โ
Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 77 KB
๐ 2 views
## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective